Vivani Medical Inc (VANI)

Dec 20, 2024

Vivani begins exenatide implant trial for obesity in Australia - Yahoo! Voices

Dec 20, 2024

Dec 19, 2024

Vivani Medical begins first human trial of implantable drug - Investing.com

Dec 19, 2024

Dec 19, 2024

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia - Business Wire

Dec 19, 2024

Dec 19, 2024

EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia - Yahoo Finance

Dec 19, 2024

Dec 04, 2024

Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast - Business Wire

Dec 04, 2024

Nov 30, 2024

Short Interest in Vivani Medical, Inc. (NASDAQ:VANI) Drops By 29.6% - MarketBeat

Nov 30, 2024

Nov 23, 2024

Financial Review: Vivani Medical (NASDAQ:VANI) vs. Heyu Biological Technology (OTCMKTS:HYBT) - Defense World

Nov 23, 2024

Nov 16, 2024

Independent Chairman of the Board of Vivani Medical Gregg Williams Buys 30% More Shares - Simply Wall St

Nov 16, 2024

Nov 14, 2024

Vivani Medical: Q3 Earnings Snapshot - Darien Times

Nov 14, 2024

Nov 13, 2024

Vivani Medical Reports Q3 Loss, Advances GLP-1 Trials - TipRanks

Nov 13, 2024

Nov 13, 2024

Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams Purchases 3,968,253 Shares - MarketBeat

Nov 13, 2024

Nov 13, 2024

Vivani medical director Gregg Williams buys $5 million in stock By Investing.com - Investing.com Nigeria

Nov 13, 2024

Nov 13, 2024

Vivani medical director Gregg Williams buys $5 million in stock - Investing.com India

Nov 13, 2024

Nov 13, 2024

Vivani Medical Secures Funding for GLP-1 Implant Trial - TipRanks

Nov 13, 2024

Nov 13, 2024

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results - Business Wire

Nov 13, 2024

Nov 11, 2024

Vivani Medical (NASDAQ:VANI) Now Covered by HC Wainwright - Defense World

Nov 11, 2024

Nov 07, 2024

HC Wainwright & Co. Initiates Coverage of Vivani Medical (VANI) with Buy Recommendation - MSN

Nov 07, 2024

Oct 22, 2024

3 US Penny Stocks To Monitor In October 2024 - Simply Wall St

Oct 22, 2024

Oct 22, 2024

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024 - Business Wire

Oct 22, 2024

Oct 17, 2024

Vivani Medical's Market Cap Up US$6.6m Following Year Of Insider Stock Buying - Simply Wall St

Oct 17, 2024

Oct 15, 2024

Vivani Medical (NASDAQ:VANI) Shares Up 0.9%Here's Why - MarketBeat

Oct 15, 2024

Oct 04, 2024

Vivani Medical's chief business officer buys shares worth $2,835 - Investing.com India

Oct 04, 2024

Oct 04, 2024

Vivani Medical's chief business officer buys shares worth $2,835 By Investing.com - Investing.com Australia

Oct 04, 2024

Oct 04, 2024

Thursday's Insider Trading Moves: Top Buys and Sells in US Stocks - Investing.com India

Oct 04, 2024

Oct 01, 2024

Precision Optics (OTCMKTS:PEYE) & Vivani Medical (NASDAQ:VANI) Head-To-Head Analysis - Defense World

Oct 01, 2024

Sep 27, 2024

Vivani Medical (NASDAQ:VANI) Stock Quotes, Forecast and News Summary - Benzinga

Sep 27, 2024

Sep 27, 2024

Vivani Medical obtains Australian approval to begin GLP-1 implant trial - Yahoo Finance

Sep 27, 2024

Sep 26, 2024

Vivani Medical's implant trial gets Australian regulatory nod - Investing.com Australia

Sep 26, 2024

Sep 26, 2024

Vivani Medical's implant trial gets Australian regulatory nod By Investing.com - Investing.com Canada

Sep 26, 2024

Sep 26, 2024

Vivani Medical to Test Implant in Obese and Overweight Patients - Yahoo Finance

Sep 26, 2024

Sep 26, 2024

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia - Business Wire

Sep 26, 2024

Sep 26, 2024

EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia - Yahoo Finance

Sep 26, 2024

Sep 23, 2024

Ventyx deal a sign of Sanofi’s growing interest neuro-immunology? - BioCentury

Sep 23, 2024

Sep 23, 2024

Sanofi gains exclusivity rights to Ventyx’s CNS-penetrant drug in $27m deal - Yahoo! Voices

Sep 23, 2024

Sep 23, 2024

Ventyx stock climbs 8% on $27M Sanofi investment - MSN

Sep 23, 2024

Sep 23, 2024

Sanofi scoops negotiation rights to Ventyx obesity, Parkinson's candidate for $27M - Fierce Biotech

Sep 23, 2024

Sep 23, 2024

Vicebio secures $100m to advance RSV and hMPV vaccine combo to Phase I - Pharmaceutical Technology

Sep 23, 2024

Sep 23, 2024

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024 - Business Wire

Sep 23, 2024

Sep 23, 2024

Ventyx Biosciences Shares Rise Premarket on Sanofi Investment - Marketscreener.com

Sep 23, 2024

Sep 23, 2024

Commonwealth Equity Services LLC Has $416,000 Stock Position in Vivani Medical, Inc. (NASDAQ:VANI) - Defense World

Sep 23, 2024

Sep 22, 2024

Viva Leisure Continues Share Buy-Back Initiative - TipRanks

Sep 22, 2024

Sep 21, 2024

First Eagle Investment Management LLC Purchases New Holdings in Silvaco Group, Inc. (NASDAQ:SVCO) - MarketBeat

Sep 21, 2024

Sep 20, 2024

Form 425 Revelyst, Inc. Filed by: Vista Outdoor Inc. - StreetInsider.com

Sep 20, 2024

Sep 20, 2024

Vista Outdoor Board of Directors Sends Letter to Stockholders Highlighting Reasons to Vote FOR Value Maximizing CSG Transaction - Yahoo Finance

Sep 20, 2024

Sep 19, 2024

Viva Leisure Continues Share Buy-Back Effort - TipRanks

Sep 19, 2024

Sep 19, 2024

Vista Outdoor considering sale of Revelyst, urges transaction with CSG - MSN

Sep 19, 2024

Sep 19, 2024

Vista Outdoor considering sale of Revelyst, urges transaction with CSG (VSTO) - Seeking Alpha

Sep 19, 2024

Sep 17, 2024

Vivani Medical (NASDAQ:VANI) Shares Down 2.3% - MarketBeat

Sep 17, 2024